Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Katie Ewer, Kailan Sierra-Davidson, Ahmed M. Salman, et al.
Vaccine (2015) Vol. 33, Iss. 52, pp. 7444-7451
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper, Brandon K. Sack, C. Richter King, et al.
Cell Host & Microbe (2018) Vol. 24, Iss. 1, pp. 43-56
Open Access | Times Cited: 299
T cell-mediated immunity to malaria
Samarchith P. Kurup, Noah S. Butler, John T. Harty
Nature reviews. Immunology (2019) Vol. 19, Iss. 7, pp. 457-471
Open Access | Times Cited: 205
<p>Recent Progress in the Development of New Antimalarial Drugs with Novel Targets</p>
Tafere Mulaw Belete
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3875-3889
Open Access | Times Cited: 113
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 81
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
Robert J. Ragotte, Matthew K. Higgins, Simon J. Draper
Trends in Parasitology (2020) Vol. 36, Iss. 6, pp. 545-559
Open Access | Times Cited: 63
Plasmodium falciparum pre-erythrocytic stage vaccine development
Jessica Molina-Franky, Laura Cuy-Chaparro, Anny Camargo, et al.
Malaria Journal (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 51
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
Carolyn M. Nielsen, Ane Ogbe, Isabela Pedroza‐Pacheco, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 3, pp. 100207-100207
Open Access | Times Cited: 44
Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy
Tom Ford, Claire Wenden, Alison Mbekeani, et al.
Vaccine (2017) Vol. 35, Iss. 15, pp. 1898-1906
Open Access | Times Cited: 44
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M. Bliss, Georgina Bowyer, Nicholas Anagnostou, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 41
Vaccination With Sporozoites: Models and Correlates of Protection
Yun Shan Goh, Daniel McGuire, Laurent Rénia
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 41
Priorities for developing respiratory syncytial virus vaccines in different target populations
Simon B. Drysdale, Rachael Barr, Christine S. Rollier, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 535
Open Access | Times Cited: 37
Correlates of malaria vaccine efficacy
Danielle I. Stanisic, Matthew B. B. McCall
Expert Review of Vaccines (2021) Vol. 20, Iss. 2, pp. 143-161
Open Access | Times Cited: 30
CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
Georgina Bowyer, Amy Grobbelaar, Tommy Rampling, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 37
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
Gustavo Cabral‐Miranda, Matthew D. Heath, Mona O. Mohsen, et al.
Vaccines (2017) Vol. 5, Iss. 2, pp. 10-10
Open Access | Times Cited: 34
New dimensions in the field of antimalarial research against malaria resurgence
Anudeep Kumar Narula, Chandra S. Azad, Lalit Mohan Nainwal
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111353-111353
Closed Access | Times Cited: 30
Host-targeted Interventions as an Exciting Opportunity to Combat Malaria
Kamalakannan Vijayan, Ling Wei, Elizabeth K. K. Glennon, et al.
Chemical Reviews (2021) Vol. 121, Iss. 17, pp. 10452-10468
Closed Access | Times Cited: 23
Malaria vaccines
Michael Quagliata, Anna Maria Papini, Paolo Rovero
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 3, pp. 169-178
Closed Access | Times Cited: 9
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
Teresa Lambe, Georgina Bowyer, Katie Ewer
Philosophical Transactions of the Royal Society B Biological Sciences (2017) Vol. 372, Iss. 1721, pp. 20160295-20160295
Open Access | Times Cited: 31
Correlating efficacy and immunogenicity in malaria vaccine trials
Matthew B. B. McCall, Peter G. Kremsner, Benjamin Mordmüller
Seminars in Immunology (2018) Vol. 39, pp. 52-64
Closed Access | Times Cited: 30
The use of transgenic parasites in malaria vaccine research
Ahmad Syibli Othman, Catherin Marin-Mogollon, Ahmed M. Salman, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 7, pp. 685-697
Open Access | Times Cited: 29
Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens
Paulo Bettencourt
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 27
A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies
Yenni Yusuf, Tatsuya Yoshii, Mitsuhiro Iyori, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 26
Memory CD8 + T cell‐mediated protection against liver‐stage malaria
Mariah Hassert, Sahaana Arumugam, John T. Harty
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 84-103
Open Access | Times Cited: 8
Development of respiratory syncytial virus (RSV) vaccines for infants
Hannah E. Gerretsen, Charles Sande
Journal of Infection (2017) Vol. 74, pp. S143-S146
Open Access | Times Cited: 27
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Cal Koger-Pease, Dilhan J. Perera, Momar Ndao
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 334-334
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top